Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
Zhuoya Deng, Yuying Tian, Jianxun Song, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 405
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak, et al.
The Lancet (2024) Vol. 403, Iss. 10427, pp. 632-644
Closed Access | Times Cited: 217
mRNA vaccines for cancer immunotherapy
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 218-218
Open Access | Times Cited: 71
Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 56
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis
Pathogens (2023) Vol. 12, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 51
Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
Asad Mustafa Karim, Jeong Eun Kwon, Tanveer Ali, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115545-115545
Closed Access | Times Cited: 40
The Multifaceted Role of Tissue-Resident Memory T Cells
Susan N. Christo, Simone L. Park, Scott N. Mueller, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 317-345
Closed Access | Times Cited: 16
Exosome for mRNA delivery: strategies and therapeutic applications
Zoya Iqbal, Khurrum Rehman, Ayesha Mahmood, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Yaxian Kong, Jingyao Li, Xia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
Defeng Li, Qisong Liu, Meifeng Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 36
Nanovaccines: An effective therapeutic approach for cancer therapy
Sangiliyandi Gurunathan, Thangaraj Pratheep, Lin Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115992-115992
Open Access | Times Cited: 23
Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact
Saber İmani, Oya Tagit, Chantal Pichon
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines
Junyan Li, Yuanyuan Wu, Xiang Jian, et al.
Chemical Engineering Journal (2022) Vol. 456, pp. 140930-140930
Open Access | Times Cited: 36
Emergence of mRNA vaccines in the management of cancer
Mohamad Irfan Mohamad Razif, Nabilah Nizar, Nur Hannah Zainal Abidin, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 629-642
Open Access | Times Cited: 17
Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
Maryam Youssef, Cynthia Hitti, Julia Puppin Chaves Fulber, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1497-1497
Open Access | Times Cited: 17
Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 16
Alginate-Chitosan Biodegradable and Biocompatible Based Hydrogel for Breast Cancer Immunotherapy and Diagnosis: A Comprehensive Review
Pratikshya Patra, Tarun Kumar Upadhyay, Nawaf Alshammari, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 6, pp. 3515-3534
Open Access | Times Cited: 6
Lipid Nanoparticle-Based Delivery System─A Competing Place for mRNA Vaccines
Xinyu Zhang, Yuanfang Li, Zehua Zhou
ACS Omega (2024) Vol. 9, Iss. 6, pp. 6219-6234
Open Access | Times Cited: 5
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Antitumor mRNA vaccines based on neoantigens
Ekaterina V. Starostina, L. F. Nizolenko, Л. И. Карпенко, et al.
Siberian Journal of Oncology (2025) Vol. 23, Iss. 6, pp. 149-158
Open Access
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
Ionizable Lipids with Branched Linkers Enhance the Delivery of mRNA Vaccines
Ji‐Wei Liu, Wenjing Sun, Bing Xiao, et al.
ACS Applied Materials & Interfaces (2025) Vol. 17, Iss. 9, pp. 13552-13564
Closed Access
Page 1 - Next Page

Scroll to top